Quetiapina ratiopharm

Quetiapina ratiopharm is a generic pharmaceutical product used primarily for the treatment of mental health conditions such as schizophrenia and bipolar disorder. The brand ratiopharm is one of the most recognized names in the generic medicine industry, originally established in Germany. Due to its global supply chain, the manufacturing of ratiopharm products occurs in multiple countries across Europe and beyond, depending on the specific facility certified for production.

The ratiopharm brand was founded in 1974 by Adolf Merckle and became Germany's first producer of generic drugs. Over the years, the brand underwent significant ownership changes. In 2010, it was acquired by Teva Pharmaceutical Industries Ltd., an Israeli multinational company that is currently the world's largest manufacturer of generic medicines. Today, ratiopharm operates as a core subsidiary of Teva, benefiting from their extensive research, development, and distribution network.